Descriptive clinical success rates at test of cure (TOC) and follow-up according to the pneumonia severity index (PSI) (intention-to-treat population)
| PSI class | Moxifloxacin | Standard treatment | ||
| SRT (monotherapy or combination) | Monotherapy (amoxicillin or clarithromycin) | Combination (amoxicillin+clarythromicin) | ||
| I# | 77/80 (96.3) | 95/98 (96.9) | 45/47 (95.7) | 50/51 (98.0) |
| II# | 50/52 (96.2) | 54/56 (96.4) | 20/20 (100) | 34/36 (94.4) |
| III# | 50/56 (89.3) | 49/53 (92.5) | 17/19 (89.5) | 32/34 (94.1) |
| IV# | 38/41 (92.7) | 28/34 (82.4) | 12/14 (85.7) | 16/20 (80.0) |
| V# | 3/4 (75.0) | 3/3 (100.0) | 1/1 (100.0) | 2/2 (100.0) |
| I¶ | 71/75 (94.7) | 91/94 (96.7) | 42/45 (93.3) | 49/49 (100.0) |
| II¶ | 46/47 (97.9) | 51/55 (92.7) | 20/20 (100.0) | 31/35 (88.6) |
| III¶ | 49/53 (92.5) | 45/49 (91.8) | 45/49 (91.8) | 15/18 (83.3) |
| IV¶ | 27/30 (90.0) | 28/33 (84.8) | 28/33 (84.8) | 11/13 (84.6) |
| V¶ | 3/3 (100.0) | 3/3 (100.0) | 1/1 (100.0) | 2/2 (100.0) |
Data are presented as n (%)
SRT: standard regimen therapy
#: clinical cure at TOC (7–10 days post-therapy)
¶: clinical cure at follow-up (28–35 days post-therapy)